Medication Maintenance Therapy in Community Pharmacy Settings

• Status: Recruiting
• Trial end date: 2022-07-31
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to compare pharmacy-based medication assisted treatment (MAT) with usual care MAT for people with opioid use disorder.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Lifespan
• Collaborators: The Miriam Hospital; University of Rhode Island
• Treatments: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone; Naltrexone

Criteria

Inclusion Criteria:

• 18 years of age or older

• English speaking

• Currently enrolled at a MAT site for the treatment of OUD, maintained on a stable MAT (BNX, NTX) dose for at least 2 days

• Able and willing to provide written informed consent and secondary contact

Exclusion Criteria:

• currently pregnant or trying to get pregnant;

• plans to move or leave the state during the study, including pending legal action;

• self reported past year suicide attempt or self-reported past year suicidal thoughts with a plan;

• Patient is currently being treated for an acute illness or has a condition that is not stable including but not limited to an upcoming surgical procedure, hospitalization, or complex treatment regimen (e.g., chemotherapy, HCV treatment, has surgery scheduled, has procedures anticipated, has anticipated dose changes with other medication), that is likely to require ongoing, intense clinical management